360 related articles for article (PubMed ID: 25735801)
21. In vitro characteristics and in vivo plasma disposition of cisplatin conjugated with oxidized and dicarboxymethylated dextrans.
Nakashima M; Ichinose K; Kanematsu T; Masunaga T; Ohya Y; Ouchi T; Tomiyama N; Sasaki H; Ichikawa M
Biol Pharm Bull; 1999 Jul; 22(7):756-61. PubMed ID: 10443480
[TBL] [Abstract][Full Text] [Related]
22. RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin.
Zhang L; Li G; Gao M; Liu X; Ji B; Hua R; Zhou Y; Yang Y
Colloids Surf B Biointerfaces; 2016 Aug; 144():81-89. PubMed ID: 27070055
[TBL] [Abstract][Full Text] [Related]
23. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system.
Ding D; Zhu Z; Li R; Li X; Wu W; Jiang X; Liu B
ACS Nano; 2011 Apr; 5(4):2520-34. PubMed ID: 21428432
[TBL] [Abstract][Full Text] [Related]
24. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor.
Föst C; Duwe F; Hellriegel M; Schweyer S; Emons G; Gründker C
Oncol Rep; 2011 May; 25(5):1481-7. PubMed ID: 21331448
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.
Chen Y; Fang L; Zhou W; Chang J; Zhang X; He C; Chen C; Yan R; Yan Y; Lu Y; Xu C; Xiang G
J Nanobiotechnology; 2021 Aug; 19(1):246. PubMed ID: 34399762
[TBL] [Abstract][Full Text] [Related]
26. A poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery.
Xiong Y; Jiang W; Shen Y; Li H; Sun C; Ouahab A; Tu J
Biomaterials; 2012 Oct; 33(29):7182-93. PubMed ID: 22795851
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell.
Ahmad Z; Tang Z; Shah A; Lv S; Zhang D; Zhang Y; Chen X
Macromol Biosci; 2014 Sep; 14(9):1337-45. PubMed ID: 24933015
[TBL] [Abstract][Full Text] [Related]
28. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery.
Alibolandi M; Mohammadi M; Taghdisi SM; Ramezani M; Abnous K
Carbohydr Polym; 2017 Jan; 155():218-229. PubMed ID: 27702507
[TBL] [Abstract][Full Text] [Related]
29. Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis.
Fei L; Huimei H; Dongmin C
Biochem Biophys Res Commun; 2020 Dec; 533(4):853-860. PubMed ID: 33008601
[TBL] [Abstract][Full Text] [Related]
30. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
31. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.
Huang J; Qian W; Wang L; Wu H; Zhou H; Wang AY; Chen H; Yang L; Mao H
Int J Nanomedicine; 2016; 11():3087-99. PubMed ID: 27462153
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
[TBL] [Abstract][Full Text] [Related]
33. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.
Sun HP; Su JH; Meng QS; Yin Q; Zhang ZW; Yu HJ; Zhang PC; Wang SL; Li YP
Acta Pharmacol Sin; 2016 Jul; 37(7):941-9. PubMed ID: 27133295
[TBL] [Abstract][Full Text] [Related]
34. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
35. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
[TBL] [Abstract][Full Text] [Related]
36. LHRH receptor targeted therapy for breast cancer.
Kakar SS; Jin H; Hong B; Eaton JW; Kang KA
Adv Exp Med Biol; 2008; 614():285-96. PubMed ID: 18290339
[TBL] [Abstract][Full Text] [Related]
37. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
38. Enhanced cellular uptake of LHRH-conjugated PEG-coated magnetite nanoparticles for specific targeting of triple negative breast cancer cells.
Hu J; Obayemi JD; Malatesta K; Košmrlj A; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():32-45. PubMed ID: 29636136
[TBL] [Abstract][Full Text] [Related]
39. Co-delivery of cisplatin and CJM-126 via photothermal conversion nanoparticles for enhanced synergistic antitumor efficacy.
You C; Wu H; Wang M; Gao Z; Zhang X; Sun B
Nanotechnology; 2018 Jan; 29(1):015601. PubMed ID: 29130888
[TBL] [Abstract][Full Text] [Related]
40. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
